MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000442298

Медицинская библиотека · Cerebrovascular diseases (Basel, Switzerland) · 2016

Research Progresses in Understanding the Pathophysiology of Moyamoya Disease.

Bersano Anna, Guey Stephanie, Bedini Gloria, Nava Sara, Hervé Dominique, Vajkoczy Peter, Tatlisumak Turgut, Sareela Marika, van der Zwan Albert, Klijn Catharina J M, Braun Kees P J, Kronenburg Annick, Acerbi Francesco, Brown Martin M, Calviere Lionel, Cordonnier Charlotte, Henon Hilde, Thines Laurent, Khan Nadia, Czabanka M, Kraemer Markus, Simister Robert, Prontera Paolo, Tournier-Lasserve E, Parati Eugenio, European Moyamoya Disease Initiative

СтатьяПоддержка исследования: вне правительства СШАОбзорПеревод пока не подготовлен

Аннотация

BACKGROUND

The pathogenesis of moyamoya disease (MMD) is still unknown. The detection of inflammatory molecules such as cytokines, chemokines and growth factors in MMD patients' biological fluids supports the hypothesis that an abnormal angiogenesis is implicated in MMD pathogenesis. However, it is unclear whether these anomalies are the consequences of the disease or rather causal factors as well as these mechanisms remain insufficient to explain the pathophysiology of MMD. The presence of a family history in about 9-15% of Asian patients, the highly variable incidence rate between different ethnic and sex groups and the age of onset support the role of genetic factors in MMD pathogenesis. However, although some genetic loci have been associated with MMD, few of them have been replicated in independent series. Recently, RNF213 gene was shown to be strongly associated with MMD occurrence with a founder effect in East Asian patients. However, the mechanisms leading from RNF213 mutations to MMD clinical features are still unknown.

SUMMARY: The research on pathogenic mechanism of MMD is in its infancy. MMD is probably a complex and heterogeneous disorder, including different phenotypes and genotypes, in which more than a single factor is implicated.

KEY MESSAGE: Since the diagnosis of MMD is rapidly increasing worldwide, the development of more efficient stratifying risk systems, including both clinical but also biological drivers became imperative to improve our ability of predict prognosis and to develop mechanism-tailored interventions.

Для цитирования: Bersano Anna, Guey Stephanie, Bedini Gloria, Nava Sara, Hervé Dominique, Vajkoczy Peter, Tatlisumak Turgut, Sareela Marika, van der Zwan Albert, Klijn Catharina J M, Braun Kees P J, Kronenburg Annick, Acerbi Francesco, Brown Martin M, Calviere Lionel, Cordonnier Charlotte, Henon Hilde, Thines Laurent, Khan Nadia, Czabanka M, Kraemer Markus, Simister Robert, Prontera Paolo, Tournier-Lasserve E, Parati Eugenio, European Moyamoya Disease Initiative. Research Progresses in Understanding the Pathophysiology of Moyamoya Disease.. Cerebrovascular diseases (Basel, Switzerland). 2016. DOI: 10.1159/000442298.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.